Pharmac to fund an additional ADHD medicine to increase supply and access
Source: PHARMAC Pharmac will fund an additional brand of methylphenidate for people with ADHD – Methylphenidate Sandoz XR – from 1 December 2025. This follows public consultation and is part of our efforts to improve access to ADHD treatment and ease ongoing supply issues. Methylphenidate Sandoz XR will be available in the same strengths as … Read more